BLOOMBERG BUSINESSWEEK: A US company will next month report the results of its study of abiraterone acetate plus prednisone for the treatment of patients with metastatic advanced prostate cancer, also called castration-resistant prostate cancer. READ MORE>
Blog Stats
- 292,091 hits
Search
Prostablog RSS – click here- PSA treachery hits close to home May 18, 2019
- Coming up to a decade clear June 4, 2018
- Let’s make more use of support groups March 13, 2017
PROSTABLOG pages
Category cloud
COMMENTS
Leave a Reply